Skip to content →

Ono Pharma Foundation Breakthrough Science Initiative 2022 (LSO)

Opportunity: Ono Pharma Foundation Breakthrough Science Initiative 2022

Sponsor: Ono Pharma Foundation

Amount: $300,00 per year, up to three years. For each year up to an additional 15% may be provided for indirect costs.

Internal deadline: 01/10/2022 at 12:00 PM EST

Description: The Ono Pharma Foundation’s 2022 Breakthrough Science Initiative Awards Program, “Ono Initiative”, looks to accelerate research-driven open innovation in the field of Chemical Biology by supporting high-risk and high-reward science research with the potential to impact therapeutic approaches to disease and pain management.

Harvard University, as a single institution**, may nominate two proposals for consideration. The Office of the Vice Provost for Research is facilitating an internal application and review process for eligible applicants.

** Please note, for this opportunity, with the exception of the Broad institute of Harvard & MIT, and the Beth Israel Deaconess Medical Center, Harvard University and affiliated institutions are viewed as a single entity by the Ono Pharma Foundation. As such, all applications should be made using the application published in the Harvard University Funding Portal, (HUFP).**

The Ono Pharma foundation does not specify a specific research area in Chemical Biology. The field is left deliberately broad so as not to disqualify potentially innovative and groundbreaking proposals.

For additional information and to apply, please click here






Published in Active External Funding External Funding

Skip to toolbar